Auro Nair

Dr. Nair, executive vice president of The Jackson Laboratory and president, JAX® Mice, Clinical and Research Services, joined The Jackson Laboratory in 2007 as associate general manager of JAX® Mice and Services. The institution added clinical services to its offerings, and in 2011 Nair was named general manager of JAX® Clinical and Research Services, responsible for all clinical and scientific research services provided to internal researchers at The Jackson Laboratory and external researchers worldwide. In 2014 he was promoted to general manager, JAX® Mice, Clinical and Research Services with responsibility for all mouse production and operations added to his portfolio. He was named to his present post in 2017. Nair was promoted to president, JAX® Mice, Clinical and Research Services, in 2017 and was also promoted to executive vice president of The Jackson Laboratory in 2018.

Prior to joining JAX, Nair served as vice president for worldwide marketing and North American sales with Caliper Life Sciences (today part of PerkinElmer), Hopkinton, Mass., where he had been responsible for commercialization of Caliper’s products and services. He had been with Caliper and its predecessor company, Zymark, since 1997. From 1990 to 1997 Nair had managed Quality Compliance and Analytical Services at GlaxoSmithKline’s FDA-approved site in Singapore. Nair is a graduate in chemistry from the University of Science, Penang, Malaysia; holds a Ph.D. in chemistry from the University of Oklahoma, Norman; and has an Executive MBA from Suffolk University in Boston, Mass.